Дисертації з теми "Cardiac a"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 дисертацій для дослідження на тему "Cardiac a".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте дисертації для різних дисциплін та оформлюйте правильно вашу бібліографію.
McDonald, Cameron. "Investigations in Cardiac Development and Cardiac Regeneration." Thesis, Griffith University, 2009. http://hdl.handle.net/10072/366063.
Повний текст джерелаThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Biomolecular and Physical Sciences
Science, Environment, Engineering and Technology
Full Text
Paul, Ashok Abraham. "Investigation of cardiac and non-cardiac drugs that modulate cardiac Herg K⺠channels." Thesis, University of Bristol, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274632.
Повний текст джерелаBaily, James Edward. "Role of cardiac perivascular cells in cardiac repair." Thesis, University of Edinburgh, 2015. http://hdl.handle.net/1842/15846.
Повний текст джерелаGràcia, Sánchez Laura Maria. "Tomografía por emisión de positrones con 18F-FDG en patología cardíaca y vascular." Doctoral thesis, Universitat Autònoma de Barcelona, 2016. http://hdl.handle.net/10803/399846.
Повний текст джерела18F-FDG PET/CT is a valuable diagnostic tool in the evaluation of inflammatory and infection diseases. Appropriate patient preparation is important because the diagnostic accuracy of this procedure depends on an adequate suppression of physiologic glucose uptake in the myocardium. There are different methods to reduce myocardial 18F-FDG uptake, such as long fasting period, high fat and low-carbohydrate diet and the administration of heparin some minutes before the 18F-FDG dose injection only if there is no counter-indication Due to their pathological background or their individual characteristics, many patients are unable to do fast for many hours or to follow high fat and low-carbohydrate diet before the scan. The administration of heparin some minutes before the 18F-FDG dose injection is the only method to try to do an adequate suppression of physiologic glucose uptake in the myocardium. However, not always the heparin’s method works properly doing a suppression of physiologic glucose uptake in the myocardium. The aim of this project is to try to know when the heparin is going to be effective, depending on the pathological background of patients, chronic treatment and individual characteristics. Therefore, if it is known in which subjects is not going to be effective we could avoid treating them. 479 subjects were evaluated (230 women), mean age 65 years old (22-86) with indication of 18F-FDG PET/CT due to an oncological illness, or infection or inflammatory suspect of a cardiac or vascular process. Five groups of subjects were studied: Subjects with diabetes mellitus, subjects with dyslipidemia under chronic lipid lowering therapy, subjects with dyslipidemia but without chronic treatment for dyslipidemia, subjects with metabolic syndrome (diabetes and dyslipidemia coexistence) and the last group of normal subjects, without diabetes nor dyslipidemia. We compare two methods. One is based on at least 6 hours of fasting and the second one is based on at least 6 hours of fasting plus the administration of heparin some minutes before the 18F-FDG dose injection. We compare the suppression of physiologic glucose uptake in the myocardium in the different groups of study with both methodologies. The heparin method obtains more suppression of physiologic glucose uptake in the myocardium, with statistically significant results in all the global population and in the group with dyslipidemia but without chronic treatment for dyslipidemia. The heparin method obtains a bigger number of subjects but with no statistically significant results in the normal group and in the metabolic syndrome group. In these groups we should perform regularly the heparin methodology searching for an adequate suppression of physiologic glucose uptake in the myocardium. In contrast to those results, we observe that the heparin method is not useful with almost statistically significant results in the diabetes mellitus group, and in the group with dyslipidemia under chronic lipid lowering therapy. In these groups we should only perform long fasting period methodology. After the results obtained in this project we have confirmed the utility of heparin administration in our community, and the best way to use it with the appropriate subjects, depending on their pathological background, chronic treatment and individual characteristics.
Burford, Evans J. "Myocyte Derived Cardiac Spheroids for Post Infarct Cardiac Regeneration." Digital WPI, 2014. https://digitalcommons.wpi.edu/etd-theses/145.
Повний текст джерелаStirparo, G. G. "DEFINITION OF TRANSCRIPTIONAL LANDSCAPE IN CARDIAC MATURATION AND CARDIAC HYPERTROPHY." Doctoral thesis, Università degli Studi di Milano, 2014. http://hdl.handle.net/2434/247064.
Повний текст джерелаVeiga, Viviane Cordeiro 1976. "Avaliação ecocardiografica da terapia de ressincronização cardiaca : dois anos de seguimento." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311904.
Повний текст джерелаDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-12T15:05:14Z (GMT). No. of bitstreams: 1 Veiga_VivianeCordeiro_M.pdf: 4383215 bytes, checksum: 4ac235c87c9173ad91395fd7c6466208 (MD5) Previous issue date: 2008
Resumo: Introdução A terapia de ressincronização cardíaca é uma opção efetiva nos pacientes com insuficiência cardíaca avançada. No entanto, 20 a 30% dos pacientes não apresentam benefícios à esta terapêutica. Critérios clínicos, eletrocardiográficos e ecocardiográficos têm sido estudados na tentativa de selecionar os pacientes que serão beneficiados com a ressincronização cardíaca, sendo o ecocardiograma um método utilizado tanto na seleção, quanto na avaliação e otimização desta terapêutica. Objetivo: O objetivo deste trabalho é analisar a utilização do ecocardiograma na avaliação da terapia de ressincronização cardíaca em pacientes portadores de insuficiência cardíaca refratária, no seguimento a curto prazo (dez dias) e após dois anos de evolução. Casuística e Método: Foram avaliados 20 pacientes com indicação de implante de marcapasso biventricular para terapia de ressincronização cardíaca no período de dois anos, sendo 16 (80%) do sexo masculino, com idade variando de 27 a 80 anos (59,70 ± 12,59 anos). A etiologia da cardiomiopatia era isquêmica em 10 pacientes (50%), chagásica em seis (30%) e idiopática em 4 (20%). Quinze pacientes encontravam-se em classe funcional III (New York Heart Association) e cinco em classe funcional IV no momento do implante do marcapasso. Foi aplicado o Questionário de Qualidade de Vida de Minnesota e realizado o teste de caminhada de seis minutos para avaliação das condições clínicas dos pacientes. Realizado ecodopplercardiograma bidimensional para avaliação da função ventricular, diâmetros cavitários, índice de performance miocárdica, estudo da dissincronia interventricular (avaliação do atraso eletromecânico entre os ventrículos esquerdo e direito) e intraventricular (análise pelo modo unidimensional e Doppler tecidual), da função diastólica e do grau da regurgitação mitral. Dez dias após o implante do marcapasso biventricular, foi repetida toda a avaliação inicial e, novamente, após dois anos. Resultados: Em dois anos, cinco pacientes (25%) foram à óbito, sendo que destes, quatro apresentavam etiologia chagásica. A duração média do complexo QRS era de 154,5±18,48 x 129,0±22,91 x 134,0±24,14 ms, respectivamente nos períodos pré-operatório, dez dias e dois anos de pós-operatório. Não houve alteração estatisticamente significante da fração de ejeção entre os períodos pré-operatório e dez dias, mas houve alteração significante entre os períodos pré-operatório e dois anos e dez dias e dois anos. No seguimento de dez dias, houve piora da dissincronia intraventricular avaliada pelo Doppler tecidual, assim como a pontuação no escore de qualidade de vida foi maior, no grupo óbito. Conclusão: A ecocardiografia é uma tecnologia em evolução e dos parâmetros avaliados, somente a avaliação da dissincronia intraventricular pelo Doppler tecidual após o procedimento, foi capaz de predizer a eficácia da terapia de ressincronização cardíaca, em relação à mortalidade. Não houve correlação entre os parâmetros ecocardiográficos e a melhora clínica de alguns pacientes.
Abstract: Introduction In the cardiac resynchronization therapy is an effective option for patients with advanced heart failure. However, 20 to 30% of patients did not show benefits to this therapy. Clinical criteria, electrocardiography and the echocardiography have been studied in an attempt to select the patients who will benefit from the cardiac resynchronization, and the echocardiogram is a method used in both the selection, as in the evaluation and optimization of this therapy. Objective: The objective of this study is to evaluate the use of echocardiography in the evaluation of patients undergoing cardiac resynchronization therapy for a period of two years. Patients and Methods: We evaluated 20 patients with the implantation of biventricular pacemaker for cardiac resynchronization therapy for over two years, and 16 (80%) males, ranging in age from 27 to 80 years (59.70±12.59 years). The etiology of cardiomyopathy was ischemic in 10 patients (50%), Chagas disease in six (30%) and idiophatic in 4 (20%). Fifteen patients were in functional class III (New York Heart Association) and five in functional class IV at the time of implantation of the pacemaker. We applied the Quality of Life Questionnaire of Minnesota and conducted the test of a six-minute walk to evaluate the clinical conditions of patients. Directed two-dimensional Doppler echocardiography for evaluation of ventricular function, cavity diameters, myocardial performance index, study of interventricular dyssynchrony (eletromechanical delay left ventricle - the right ventricle) and intraventricular (by way dimensional analysis and tissue Doppler), the diastolic function and degree of mitral regurgitation. Ten days after implantation of biventricular pacemaker, was repeated throughout the initial assessment and again after two years. Results: In two years, five patients (25%) were to death, and that these, four had Chagas disease. The average duration of the QRS complex was 154.5±18.48 x 129.0±22.91 x 134.0±24.14 ms, respectively in preoperative, ten days and two years after surgery. There was no statistically significant change in the ejection fraction between preoperative and ten days but there was significant change between periods preoperative and 2 years and 10 days and 2 years. Following ten days, the evaluation of intraventricular dyssynchrony by tissue Doppler and quality of life scores were significantly higher in the group died. Conclusion: The echocardiography is an evolving technology and the parameters evaluated, only the assessment of intraventricular dyssynchrony by Doppler tissue after the procedure was able to predict the effectiveness of the cardiac resynchronization therapy, in relation to mortality. There was no correlation between echocardiographic parameters and clinical improvement in some patients.
Mestrado
Mestre em Cirurgia
Dawson, Jennifer Elizabeth. "Cardiac Tissue Engineering." Thèse, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/20071.
Повний текст джерелаPeace, Richard Aidan. "Quantitative cardiac SPECT." Thesis, University of Aberdeen, 2001. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU602292.
Повний текст джерелаSemenas, Egidijus. "Sex Differences in Cardiac and Cerebral Damage after Hypovolemic Cardiac Arrest." Doctoral thesis, Uppsala universitet, Anestesiologi och intensivvård, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-146314.
Повний текст джерелаEde, Mauricio. "An alternative agent to induce cardiac arrest for normothermic cardiac surgery." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0022/NQ32879.pdf.
Повний текст джерелаThomas, Nia Lowri. "Molecular mechanisms underlying cardiac ryanodine receptor dysfunction in sudden cardiac death." Thesis, Cardiff University, 2005. http://orca.cf.ac.uk/54084/.
Повний текст джерелаDrexler, Samona Smith. "Quality Improvement Project| Cardiac Risk Stratification Prior to Non-Cardiac Surgery." Thesis, University of Louisiana at Lafayette, 2016. http://pqdtopen.proquest.com/#viewpdf?dispub=10163292.
Повний текст джерелаThe occurrence of major adverse cardiac events (MACE) is a common perioperative complication and contributing factor for the increase risk of morbidity and mortality in adult patients undergoing non-cardiac surgery. The most reasonable and evidence-based option to reduce the risk of MACE and perioperative morbidity and mortality is a consistent assessment of the functional capacity for non-cardiac patients prior to non-cardiac surgical procedures. According to Fleisher et al. (2014), individuals with a decreased or unmeasurable functional capacity should be referred to a cardiologist for evaluation and cardiac risk stratification prior to surgery. The Duke Activity Status Index (DASI) tool has demonstrated to be an effective tool in assessing functional capacity and identifying individuals without a known cardiac history who may be at risk for perioperative cardiac complications.
This quality improvement project focused on the implementation and use of the DASI tool into the preexisting formal preoperative procedure. Use of the DASI tool focused on accurate measurements of the surgical patient’s functional capacity and evaluation of potential risk factors for MACE. As a result of using the DASI tool in the preoperative process, several non-cardiac adult patients were recognized as being at risk for MACE and underwent cardiac interventional procedures following referral to a cardiologist for preoperative evaluation. Assessing functional capacity using the DASI tool prior to non-cardiac surgical procedures has proven to be both valuable and medically beneficial for the non-cardiac adult patients in evaluation of the risk for MACE.
Johnson, Jonas. "The Cardiac State Diagram : A new method for assessing cardiac mechanics." Doctoral thesis, KTH, Medicinsk avbildning, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-202743.
Повний текст джерелаJeffords, Megan E. "Tailoring Material Properties Of Cardiac Matrix Hydrogels For Cardiac Tissue Engineering." University of Akron / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=akron1430838968.
Повний текст джерелаYamada, Tetsu. "Impact of the cardiac arrest mode on cardiac death donor lungs." Kyoto University, 2015. http://hdl.handle.net/2433/200492.
Повний текст джерелаNicholson, Suzanne Maria. "Uncertainty in cardiac transplant recipients prior to and after cardiac catheterization." Thesis, The University of Arizona, 1987. http://hdl.handle.net/10150/276609.
Повний текст джерелаGibbons, David D. "Stabilization of the Cardiac Nervous System During Cardiac Stress Induces Cardioprotection." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etd/1219.
Повний текст джерелаBelian, Elisa. "The instructive role of cardiac transcription factors in triggering transition of cardiac progenitor cells into the cardiac muscle fate." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/40196.
Повний текст джерелаFerrer, Cuadros Debora. "Programa de prevención y rehabilitación cardíaca integral: cardiomove." Master's thesis, Universidad Peruana de Ciencias Aplicadas (UPC), 2020. http://hdl.handle.net/10757/655111.
Повний текст джерелаThe Comprehensive Cardiac Prevention and Rehabilitation Program: CARDIOMOVE; is a for-profit health company that seeks economic and social profitability, whose objective is to improve the patient clinically; both from a cardiological and psychological point of view to those who have suffered from ischemic heart disease such as; infarction or heart attack, undergoing percutaneous coronary intervention, bypass surgery, chronic stable angina, device implantation, heart transplantation, heart failure, intervention on heart valves, peripheral arterial disease, and patients without any heart disease but with a risk factor cardiovascular (hypertension, diabetes mellitus, obesity and dyslipidemias) The Comprehensive Cardiac Prevention and Rehabilitation Program: CARDIOMOVE; It is made up of fundamental pillars such as control of risk factors, improvement of physical capacity, optimization of medical treatment, education of healthy lifestyle habits, and psychological and nutritional support. Our service is aimed at the public over 18 years of age with or without heart disease, but with cardiovascular factors belonging to socioeconomic status B and C of Metropolitan Lima with the possibility of paying out of pocket. The Comprehensive Cardiac Prevention and Rehabilitation Program: CARDIOMOVE: has its headquarters located in the Jesús María district, due to the fact that it is a place with easy geographic access from the different districts of Lima. The business idea was born due to the prevalence of cardiovascular diseases, the increase in risk factors and poor promotion of healthy lifestyles, absence of cardiovascular prevention rehabilitation programs, absence of a cardiac rehabilitation program as a proven secondary prevention strategy, misinformation about the great benefits of cardiac rehabilitation; the scarce referral of patients to these programs almost non-existent and the growth of non-communicable diseases Our value proposition is to improve the quality of life; reincorporating him to work and socially; avoiding psychological deterioration, strengthening physical capacity; providing a unique and safe experience; through multidisciplinary and personalized care for people who require a comprehensive cardiac prevention and rehabilitation program. All this is possible with a professional health and administrative human team, whose main values are: Hospitality, Respect, Responsibility, Quality and Spirituality. Regarding the financial economic evaluation; An investment of S / 427,369 nuevos soles has been estimated, which is financed 30% by capital and 70% by debt. With an average sale price for a complete package of the comprehensive cardiac prevention and rehabilitation program of S /. 1,440 nuevos soles, a monthly cost of S / 480 nuevos soles and an average unit variable cost of S /. 40 new soles. With a return on investment of 1 years. Obtaining a net present economic value of the company of approximately S / 1,067.984 new soles. Regarding the Internal Rate of Return of the company it corresponds to 30.83%. After the above, according to the financial profitability data and sensitivity studies, it is concluded that it is a low risk investment with a great possibility of growth over time coupled with a great impact on people's health.
Trabajo de investigación
Mayfield, Audrey. "Encapsulation of Cardiac Stem Cells to Enhance Cell Retention and Cardiac Repair." Thesis, Université d'Ottawa / University of Ottawa, 2014. http://hdl.handle.net/10393/31500.
Повний текст джерелаYılmaz, Ayten. "Studies on cardiac pacing emphasis on pacemaker sensors and cardiac resynchronization therapy /." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2005. http://dare.uva.nl/document/79548.
Повний текст джерелаWilliams, Lynne Kirsty. "Mechanisms by which cardiac resynchronisation therapy improves cardiac performance in heart failure." Thesis, University of Birmingham, 2010. http://etheses.bham.ac.uk//id/eprint/1051/.
Повний текст джерелаMendoza, James Patrick. "The cardiac myocyte-specific role of PKG-1 alpha in cardiac remodeling." Thesis, Boston University, 2012. https://hdl.handle.net/2144/12517.
Повний текст джерелаCurrent dogma holds that the cGMP dependent protein kinase (PKG) acts in the cardiovascular system (CVS) mainly through the vascular smooth muscle cell (VSMC) to regulate blood flow and vascular tone via nitric oxide (NO) induced vasodilation. Yet, the role of PKG in the CVS, outside the VSMC, remains largely unexplored. Recent studies have revealed that PKG also functions as an anti-hypertrophic molecule in the heart, attenuating cardiac remodeling and preventing the progression of congestive heart failure (CHF). However, those studies used pharmacological agents which increased whole-body cGMP to activate PKG. One more attractive therapeutic strategy would be to activate PKG in cell-types specific to the heart, but not to the peripheral vasculature, since this might provide a more direct treatment for CHF with fewer adverse side effects. Therefore, we tested the specific hypothesis that PKG-Iα attenuates cardiac hypertrophy and remodeling in vivo through a specific role inthe cardiac myocyte (CM). Genotypically, we compared aMHC-Cre+/-, PKG-Iαfl/fl (Cre+) mice to aMHC-Cre-/-, PKG-Iαfl/fl (Cre-) control mice. Here we have shown that Cre+ mice lose the ability to inhibit cardiac remodeling in an unstressed state. Cre+ mice have increased heart weights, CM size, fibrosis, and contractile dysfunction, compared to Cre- mice. Additionally, Cre+ mice show increased fetal gene expression indicative of remodeling. Lastly, these effects worsened in an age-dependent manner. These data suggest that inhibition of cardiac remodeling occurs principally through PKG-Iα in the CM, and reveal new roles for PKG in the CVS, and as a novel target for CHF therapy.
Fan, Zhaobo. "Control of Cardiac Extracellular Matrix Degradation and Cardiac Fibrosis after Myocardial Infarction." The Ohio State University, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=osu1480662216531284.
Повний текст джерелаWhelen, Elizabeth Anne. "Illness perceptions, cardiac rehabilitation and quality of life in cardiac surgery patients." Thesis, University of Manchester, 2011. https://www.research.manchester.ac.uk/portal/en/theses/illness-perceptions-cardiac-rehabilitation-and-quality-of-life-in-cardiac-surgery-patients(63ce3eb5-16c7-487a-8d51-c727a4399a19).html.
Повний текст джерелаLionetti, Fred. "GPU accelerated cardiac electrophysiology." Diss., [La Jolla] : University of California, San Diego, 2010. http://wwwlib.umi.com/cr/ucsd/fullcit?p1474756.
Повний текст джерелаTitle from first page of PDF file (viewed April 14, 2010). Available via ProQuest Digital Dissertations. Includes bibliographical references (p. 85-89).
De, Vos Jacques Pinard. "Automated pediatric cardiac auscultation." Thesis, Link to the online version, 2005. http://hdl.handle.net/10019/1008.
Повний текст джерелаLord, Stephen. "Reinnervation after cardiac transplantation." Thesis, University of Oxford, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.410568.
Повний текст джерелаBach, Thuthuy. "Computerized cardiac mapping system." Thesis, University of Ottawa (Canada), 1990. http://hdl.handle.net/10393/5878.
Повний текст джерелаLodgek, Erika. "History of Cardiac Anesthesia." The University of Arizona, 2018. http://hdl.handle.net/10150/626588.
Повний текст джерелаLipšic, Erik. "Erythropoietin in cardiac ischemia." [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2006. http://irs.ub.rug.nl/ppn/293076030.
Повний текст джерелаRobinson, Monique Renee. "Cardiac pathophysiology of obesity." Thesis, University of Oxford, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414224.
Повний текст джерелаKluvitse, C. D. "Discrimination of cardiac activity." Thesis, University of Hull, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.233949.
Повний текст джерелаAl-raqad, Mohammed. "Cardiac involvement in dystrophinopathies." Thesis, University of Newcastle Upon Tyne, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.627742.
Повний текст джерелаTaylor, Kelly A. "Benefits of cardiac rehabilitation." Honors in the Major Thesis, University of Central Florida, 2001. http://digital.library.ucf.edu/cdm/ref/collection/ETH/id/251.
Повний текст джерелаBachelors
Health and Public Affairs
Nursing
Smetana, Peter. "Dynamics of cardiac repolarisation." Thesis, St George's, University of London, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.479379.
Повний текст джерелаBourke, L. T. "Cardiac injury in lupus." Thesis, University College London (University of London), 2014. http://discovery.ucl.ac.uk/1458423/.
Повний текст джерелаCouper, Keith. "Debriefing for cardiac arrest." Thesis, University of Warwick, 2015. http://wrap.warwick.ac.uk/67921/.
Повний текст джерелаCook, Stuart Alexander. "Regulation of cardiac apoptosis." Thesis, Imperial College London, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.393164.
Повний текст джерелаAkinjolire, O. J., and J. H. Mohanad. "Open-chest cardiac massage." Thesis, Сумський державний університет, 2013. http://essuir.sumdu.edu.ua/handle/123456789/32745.
Повний текст джерелаStewart, Kelley Christine. "Hydrodynamics of Cardiac Diastole." Diss., Virginia Tech, 2011. http://hdl.handle.net/10919/26837.
Повний текст джерелаPh. D.
Semple, Scott I. K. "Clinical cardiac functional MRI." Thesis, University of Aberdeen, 2000. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU602018.
Повний текст джерелаAnaya, Demetrio Donald. "Ultrasound-Compatible Cardiac Simulator." Thesis, Harvard University, 2015. http://nrs.harvard.edu/urn-3:HUL.InstRepos:17417571.
Повний текст джерелаMechanical Engineering
Luczak, Elizabeth Diane. "Modifiers of cardiac adaptation." Connect to online resource, 2007. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3305611.
Повний текст джерелаYoussef, Asser M., Jahromi Alireza Hamidian, and Cuthbert O. Simpkins. "Arterial versus Venous Fluid Resuscitation; Restoring Cardiac Contractions in Cardiac Arrest Following Exsanguinations." BAQIYATALLAH UNIV MEDICAL SCIENCES, 2016. http://hdl.handle.net/10150/626110.
Повний текст джерелаArtis, Nigel John. "Echocardiography in the assessment of cardiac dyssynchrony and its implications for cardiac resynchronisation." Thesis, University of Leeds, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.509821.
Повний текст джерелаJackson, Katy Filer. "The experiences of partners of cardiac patients : sense of coherence and cardiac beliefs." Thesis, City University London, 2011. http://openaccess.city.ac.uk/7798/.
Повний текст джерелаWake, Emily. "The role of the intrinsic cardiac nervous system in cardiac physiology and disease." Thesis, University of Leicester, 2017. http://hdl.handle.net/2381/40499.
Повний текст джерелаDubey, Prachi. "Development of cardiac patches using medium chain length polyhydroxyalkanoates for cardiac tissue engineering." Thesis, University of Westminster, 2017. https://westminsterresearch.westminster.ac.uk/item/q32v3/development-of-cardiac-patches-using-medium-chain-length-polyhydroxyalkanoates-for-cardiac-tissue-engineering.
Повний текст джерела